259 related articles for article (PubMed ID: 12265944)
21. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
22. [Contraception and hepatogastroenterology].
Grimaud JC; Bourliere M
Fertil Contracept Sex; 1989 May; 17(5):407-13. PubMed ID: 12316076
[TBL] [Abstract][Full Text] [Related]
23. [Metabolic risks of oral contraception].
Monier L
Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
[TBL] [Abstract][Full Text] [Related]
24. [The end of IUD marketing in the United States: what does it mean for American women?].
Forrest JD
Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
[TBL] [Abstract][Full Text] [Related]
25. [Teratogenic and mutagenic risks of radiotherapy: when and how to prescribe contraception].
Marty M; Mignot L; Gisselbrecht G; Morvan F; Gorins A; Boiron M
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):181-6. PubMed ID: 12280202
[TBL] [Abstract][Full Text] [Related]
26. [Oral contraception and carbohydrate metabolism: III--practical implications].
Hilal M
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):59-62. PubMed ID: 12341242
[TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives and drug interactions. Patient guide.
Female Patient; 1992 Apr; 17(4):107-8. PubMed ID: 12345871
[TBL] [Abstract][Full Text] [Related]
28. [Oral contraception, glucid metabolism and monitoring criteria].
Gaspard U
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
[TBL] [Abstract][Full Text] [Related]
29. [Oral contraception: disadvantages of estrogen reduction].
Denis C
Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
[TBL] [Abstract][Full Text] [Related]
30. [Sex steroids and vascular risk].
Rozenbaum H
Coeur; 1983; 14(1):91-102. PubMed ID: 12339512
[TBL] [Abstract][Full Text] [Related]
31. [Dermatological complications caused by oral contraceptives].
Deharo C; Berbis P; Privat Y
Fertil Contracept Sex; 1988 Apr; 16(4):299-304. PubMed ID: 12342376
[TBL] [Abstract][Full Text] [Related]
32. Post coital contraception.
Haspels AA; Van Santen MR
J Gynaecol Endocrinol; 1986; 2(1-2):17-24. PubMed ID: 12269214
[TBL] [Abstract][Full Text] [Related]
33. [Metrorrhagia caused by estrogen-progestin combinations].
Erny R; Erny N
Contracept Fertil Sex (Paris); 1994 Feb; 22(2):93-7. PubMed ID: 12319056
[TBL] [Abstract][Full Text] [Related]
34. [The pill and the liver].
Leclere J; Meot-rossinot B; Rauber G
Lyon Mediterr Med Med Sud Est; 1983 Jan; 19(2):7075-80. PubMed ID: 12279702
[TBL] [Abstract][Full Text] [Related]
35. Looking into the future.
Potts M
Plan Parent Rev; 1983; 3(2):3-5. PubMed ID: 12265636
[TBL] [Abstract][Full Text] [Related]
36. [The eye and hormones: vascular disorders associated with combined oral contraceptives and pregnancy].
Villatte-cathelineau B
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):147-52. PubMed ID: 12280201
[TBL] [Abstract][Full Text] [Related]
37. [Veins and contraception].
Reinharez D; Monsonego J
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):131-6. PubMed ID: 12280199
[TBL] [Abstract][Full Text] [Related]
38. Vaginal contraceptives merge old forms, new data.
Contracept Technol Update; 1983 Jul; 4(7):73-5. PubMed ID: 12339358
[TBL] [Abstract][Full Text] [Related]
39. Urinary pregnanediol during the use of different contraceptive methods.
Kesseru-koos E; Noack P; Larranaga-leguia A
Acta Endocrinol Panam; 1971; 2():73-90. PubMed ID: 12256701
[TBL] [Abstract][Full Text] [Related]
40. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
